In the rapidly evolving world of biotechnology, the focus is increasingly shifting toward a patient-centric approach within the Nucleic Acid-based Therapeutics Market Segment. This involves not only developing effective treatments but also considering the patient's experience throughout the therapeutic journey. For many individuals with chronic or genetic conditions, the mode of delivery can...